70 related articles for article (PubMed ID: 20737565)
21. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
[TBL] [Abstract][Full Text] [Related]
22. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
23. PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs.
Balta G; Altay C; Gurgey A
Am J Hematol; 2002 Oct; 71(2):89-93. PubMed ID: 12353306
[TBL] [Abstract][Full Text] [Related]
24. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
[TBL] [Abstract][Full Text] [Related]
25. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
Ye S; Green FR; Scarabin PY; Nicaud V; Bara L; Dawson SJ; Humphries SE; Evans A; Luc G; Cambou JP
Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
[TBL] [Abstract][Full Text] [Related]
26. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H
J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer.
Palmirotta R; Ferroni P; Savonarola A; Martini F; Ciatti F; Laudisi A; Sini V; Del Monte G; Guadagni F; Roselli M
Thromb Res; 2009 Sep; 124(4):403-8. PubMed ID: 19351570
[TBL] [Abstract][Full Text] [Related]
28. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
Zöller B; García de Frutos P; Dahlbäck B
Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
[TBL] [Abstract][Full Text] [Related]
29. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
Song Y; Xu W; Chen Y; Che L; Wang Q; Zhou X; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):374-6. PubMed ID: 10581347
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen-activator-inhibitor-1 promoter polymorphism as a risk factor for adult periodontitis in non-smokers.
Izakovicová Hollá L; Bucková D; Fassmann A; Benes P; Znojil V
Genes Immun; 2002 Aug; 3(5):292-4. PubMed ID: 12140748
[TBL] [Abstract][Full Text] [Related]
32. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
[TBL] [Abstract][Full Text] [Related]
33. Leg ulcers revealing familial thrombophilia: prothrombin G20210A gene mutation and plasminogen activator inhibitor type 1 (PAI-1) polymorphism.
Calistru AM; Cruz MJ; Baudrier T; Gonçalves L; Azevedo F
Eur J Dermatol; 2011; 21(3):414-5. PubMed ID: 21515439
[No Abstract] [Full Text] [Related]
34. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis.
Eroglu A; Ulu A; Akar N
J Thromb Thrombolysis; 2006 Oct; 22(2):111-2. PubMed ID: 17008976
[No Abstract] [Full Text] [Related]
35. Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers.
Junker R; Nabavi DG; Wolff E; Lüdemann P; Nowak-Göttl U; Käse M; Bäumer R; Ringelstein EB; Assmann G
Thromb Haemost; 1998 Oct; 80(4):706-7. PubMed ID: 9798998
[No Abstract] [Full Text] [Related]
36. Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case-control study.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Theodoropoulou A; Livadiotaki A; Paspatis G; Kouroumalis EA
Inflamm Bowel Dis; 2007 Apr; 13(4):410-5. PubMed ID: 17206678
[TBL] [Abstract][Full Text] [Related]
37. Genetic association between plasminogen activator inhibitor-1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta-analysis.
Huang G; Wang P; Li T; Deng X
Clin Cardiol; 2019 Dec; 42(12):1232-1238. PubMed ID: 31701558
[TBL] [Abstract][Full Text] [Related]
38. Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention.
Ferroni P; Della-Morte D; Palmirotta R; McClendon M; Testa G; Abete P; Rengo F; Rundek T; Guadagni F; Roselli M
Rejuvenation Res; 2011 Jun; 14(3):293-308. PubMed ID: 21595514
[TBL] [Abstract][Full Text] [Related]
39. Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study.
Blaes AH; Mulrooney DA; Vogel RI; Solovey A; Hebbel R; Peterson BA; Neglia JP; Biewen C; Konety SH; Duprez DA
Vasc Health Risk Manag; 2018; 14():205-211. PubMed ID: 30237722
[TBL] [Abstract][Full Text] [Related]
40. Correlation between
Geng B; Li S; Zhou J; Feng G
Phlebology; 2020 Aug; 35(7):472-479. PubMed ID: 31948344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
